Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NASO-PET: Intranasal Insulin Effects on Tissue Specific Insulin Sensitivity
NCT02933645Completed
- Sponsor
- Turku University Hospital
- Start
- Apr 2016
- Primary completion
- Dec 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, single-blind trial of regular human insulin in insulin resistance (IR) (2 arms), sponsored by Turku University Hospital. Primary endpoint: Skeletal muscle glucose uptake. Started Apr 2016; status: completed.
02
Drugs
regular human insulin
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT02933645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02933645.